NASDAQ:VTGN

Vistagen Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy VTGN

*Your capital is at risk

$0.560

-0.0199 (-3.43%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

VTGN Prediction Chart

VTGN Predictions History

Latest community submissions for VTGN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Oct 28, 2020	$0.768 -96.54%	$0.740	X	96.24%	0
JS Pro	Oct 27, 2020	$0.726 -96.82%	$0.755	X	96.16%	1
Nima.Barrzz.105030	Oct 27, 2020	Bearish	$0.755	V	—	0
JS Pro	Oct 26, 2020	$0.772 -96.38%	$0.710	V	91.27%	1
JS Pro	Oct 23, 2020	$0.85 -96.38%	$0.785	X	92.16%	0
JS Pro	Oct 22, 2020	$0.775 -96.85%	$0.82	V	94.37%	0
JS Pro	Oct 21, 2020	$0.84 -96.39%	$0.780	X	91.79%	0
JS Pro	Oct 20, 2020	$0.772 -96.86%	$0.82	V	94.15%	0
JS Pro	Oct 19, 2020	$0.84 -96.48%	$0.785	X	93.63%	0
iHustle84 Pro	Oct 19, 2020	$0.98 -95.86%	$0.785	X	75.16%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VTGN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT VISTAGEN THERAPEUTICS INC

VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by